BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 108479
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.108479
Figure 2
Figure 2 Serum hepatitis B surface antigen and hepatitis B virus-DNA changes across disease phases in the observation cohort. A: Serum hepatitis B surface antigen (HBsAg) dynamics across infection phases; B: Hepatitis B virus (HBV)-DNA viral load variations by disease stage. ENH: Hepatitis B virus e antigen-negative hepatitis; IC: Immune clearance; IT: Immune tolerance; LR: Low replication. aP < 0.05 vs immune tolerance phase; bP < 0.05 vs immune clearance phase; cP < 0.05 vs low replication phase.


Write to the Help Desk